Liver biopsy
暂无分享,去创建一个
R. Nelson | D. Rockey | S. Caldwell | Alastair D. Smith | Rendon C. Nelson | Z. Goodman | Don C. Rockey | Stephen H. Caldwell | Zachary D. Goodman | Alastair D. Smith
[1] N. Mcintyre,et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. , 1993, Journal of hepatology.
[2] L. Castéra,et al. Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: A randomized placebo-controlled trial , 2001, American Journal of Gastroenterology.
[3] B. Bacon,et al. Histological evaluation of iron in liver biopsies: relationship to HFE mutations , 2000, American Journal of Gastroenterology.
[4] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[5] A. Reuben. Just a second , 2003, Hepatology.
[6] Y. Baruch,et al. Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy , 2003, Anesthesia and analgesia.
[7] T. Therneau,et al. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities , 2000, American Journal of Gastroenterology.
[8] J H Lewis,et al. Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey. , 2001, Digestive diseases and sciences.
[9] M. Fried,et al. Practice and complications of liver biopsy , 1993, Digestive Diseases and Sciences.
[10] Michael A. Choti,et al. Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy: Implications for Transplant Eligibility , 2007, Annals of surgery.
[11] American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. , 1995, Gastroenterology.
[12] M. Schilsky,et al. Diagnosis and treatment of Wilson disease: An update , 2008, Hepatology.
[13] E. Cholongitas,et al. Ultrasound‐guided liver biopsy in real life: Comparison of same‐day prebiopsy versus real‐time ultrasound approach , 2007, Journal of gastroenterology and hepatology.
[14] J. Crawford. Evidence-based interpretation of liver biopsies , 2006, Laboratory Investigation.
[15] S. Jasko,et al. Therapy , 1881, The American journal of dental science.
[16] I. Dvorchik,et al. Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?--yes. , 2005, Journal of hepatology.
[17] F. Lirussi,et al. Laparoscopy and Liver Biopsy: Further Evidence that the Two Procedures Improve the Diagnosis of Liver Cirrhosis A Retrospective Study of 1,003 Consecutive Examinations R. Orlando, M.D , 1990, Journal of clinical gastroenterology.
[18] K. Lindor,et al. Outcome of Patients Hospitalized for Complications after Outpatient Liver Biopsy , 1993, Annals of Internal Medicine.
[19] D. Rockey,et al. Pyogenic liver abscess. Changes in etiology, management, and outcome. , 1996, Medicine.
[20] K. Niezen-Koning,et al. Type IIIb glycogen storage disease associated with end‐stage cirrhosis and hepatocellular carcinoma , 1997, Hepatology.
[21] P. Mannucci,et al. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. , 2007, Journal of hepatology.
[22] Aniruddha M. Deshpande,et al. Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.
[23] H. Karakayalı,et al. Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] D. Kane,et al. Survey of arthroscopy performed by rheumatologists. , 2002, Rheumatology.
[25] R. Heyn,et al. Pretreatment liver biopsy in 20 children with histiocytosis X: a clinicopathologic correlation. , 1990, Medical and Pediatric Oncology.
[26] A. Burroughs,et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.
[27] J Rakela,et al. The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy , 1996, Hepatology.
[28] A. Czaja,et al. Optimizing diagnosis from the medical liver biopsy. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] E. Schiff,et al. The role of laparoscopy in the diagnosis of cirrhosis. , 1996, Gastrointestinal endoscopy.
[30] D. Jain,et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. , 2000, The New England journal of medicine.
[31] S. Brunskill,et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials , 2004, British journal of haematology.
[32] A. fong,et al. Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[33] J. Segal,et al. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based review , 2005, Transfusion.
[34] H. Fukui,et al. Cryptogenic cirrhosis in the region where obesity is not prevalent. , 2006, World journal of gastroenterology.
[35] W. Hathaway,et al. Use of DDAVP in inherited and acquired platelet dysfunction , 1990, American journal of hematology.
[36] Samuel Chang,et al. Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma: evaluation of doubling time, frequency, and features on CT. , 2005, AJR. American journal of roentgenology.
[37] G. Minuk,et al. Clinical hepatology: Profile of an urban, hospital‐based practic , 1996, Hepatology.
[38] T. Ganiats,et al. Ultrasound-Guided Liver Biopsy for Parenchymal Liver Disease (An Economic Analysis) , 2004, Digestive Diseases and Sciences.
[39] P. Toy,et al. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. , 1990, American journal of clinical pathology.
[40] C. Jacquelinet,et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. , 1992, Gastroenterology.
[41] C. González Hernández,et al. [Cryptogenic cirrhosis?]. , 1999, Anales de medicina interna.
[42] G. Brancatelli. Science to practice: Should biopsy be performed in potential liver donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation? , 2006, Radiology.
[43] Christos Christidis,et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.
[44] V. Beutel,et al. Prospective Randomized Trial of Post-liver Biopsy Recovery Positions: Does Positioning Really Matter? , 2005, Journal of clinical gastroenterology.
[45] R. McCallum,et al. Variation between centers in technique and guidelines for liver biopsy. , 2008, Liver.
[46] D. Triulzi. The art of plasma transfusion therapy , 2006, Transfusion.
[47] P. Thampanitchawong,et al. Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.
[48] S. Klauck,et al. Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases. , 2001, Liver.
[49] G. Alexander,et al. The role for liver biopsy in haemophiliacs infected with the hepatitis C virus , 1997, British journal of haematology.
[50] Xi-Zhang Lin,et al. The normal adult human liver biopsy: A quantitative reference standard , 1998, Hepatology.
[51] P. Schlichting,et al. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. , 1980, Scandinavian journal of gastroenterology.
[52] J. McHutchison,et al. American Gastroenterological Association technical review on the management of hepatitis C. , 2006, Gastroenterology.
[53] G. Dodd,et al. Image-guided percutaneous hepatic biopsy: effect of ascites on the complication rate. , 1996, Radiology.
[54] D. Purdie,et al. Steatosis is a cofactor in liver injury in hemochromatosis. , 2005, Gastroenterology.
[55] L. Seeff,et al. Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .
[56] M. Taniai,et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH , 2004, Journal of Gastroenterology.
[57] L. Weisenthal,et al. Delayed hemorrhage after percutaneous liver biopsy. , 1983, Journal of clinical gastroenterology.
[58] D. Rajan,et al. Pain after percutaneous liver biopsy for diffuse hepatic disease: a randomized trial comparing subcostal and intercostal approaches. , 2005, Journal of vascular and interventional radiology : JVIR.
[59] J. Ludwig,et al. Two cases from the spectrum of nonalcoholic steatohepatitis. , 1995, Journal of clinical gastroenterology.
[60] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[61] R. Bruno,et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. , 2004, Journal of hepatology.
[62] M. Colombo,et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. , 1988, Gastroenterology.
[63] X. Forns,et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation , 2006, Hepatology.
[64] Dermot Kelleher,et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. , 1999, Journal of hepatology.
[65] J. Devière,et al. Management of anticoagulants before and after endoscopy. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[66] M. Haberal,et al. Liver biopsy is mandatory to choose suitable liver grafts. , 2003, Transplantation proceedings.
[67] F. Carrat,et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. , 2005, Gastroenterology.
[68] J. Glaser,et al. [The risk of liver biopsy]. , 1995, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.
[69] G. Gerken,et al. Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[70] M. Schilsky,et al. A practice guideline on Wilson disease , 2003, Hepatology.
[71] E. Mezey,et al. Sampling variability on percutaneous liver biopsy. , 1979, Archives of internal medicine.
[72] R. P. Thompson,et al. Experience with transjugular liver biopsy. , 1983, Gut.
[73] S. Cotler,et al. Liver Transplantation for Hepatocellular Carcinoma: A Survey of Practices , 2006, Journal of clinical gastroenterology.
[74] William M. Lee,et al. AASLD Position Paper: The Management of Acute Liver Failure: Update 2011 , 2011 .
[75] K. Lindor,et al. Utility of liver biopsy in bone marrow transplant patients , 2008, Journal of gastroenterology and hepatology.
[76] H. Kumada,et al. [Chronic hepatitis B]. , 2001, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.
[77] O. Chazouilleres,et al. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology , 2007, Hepatology.
[78] P. Hall,et al. Small gauge gelfoam plug liver biopsy in high risk patients: safety and diagnostic value. , 1996, Australasian radiology.
[79] E. Heathcote. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. , 2000, Hepatology.
[80] P. Beddy,et al. Outpatient liver biopsy: a prospective evaluation of 500 cases , 2006, Gut.
[81] D. Rockey,et al. Noninvasive measures of liver fibrosis , 2006, Hepatology.
[82] L. Ferrell,et al. Cirrhosis of undefined pathogenesis: Absence of evidence for unknown viruses or autoimmune processes , 1993, Hepatology.
[83] S. Sherlock. ASPIRATION LIVER BIOPSY: TECHNIQUE AND DIAGNOSTIC APPLICATION , 1945 .
[84] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[85] C. Clerici,et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis , 2003, Hepatology.
[86] Chao-Long Chen,et al. Needle Tract Implantation of Hepatocellular Carcinoma After Fine Needle Biopsy , 2006, Digestive Diseases and Sciences.
[87] A. Dube,et al. Spectrum of Liver Histology in Presumed Decompensated Alcoholic Liver Disease , 2007, The American Journal of Gastroenterology.
[88] M. Stone,et al. An audit of ultrasound guided liver biopsies: a need for evidence-based practice. , 1996, Hepato-gastroenterology.
[89] T. Berg,et al. DISTINCT ENZYME PROFILES IN PATIENTS WITH CRYPTOGENIC CIRRHOSIS REFLECT HETEROGENEOUS CAUSES WITH DIFFERENT OUTCOMES AFTER LIVER TRANSPLANTATION (OLT): A LONG-TERM DOCUMENTATION BEFORE AND AFTER OLT , 2002, Transplantation.
[90] T. Riley. Predictors of Pain Medication Use After Percutaneous Liver Biopsy , 2002, Digestive Diseases and Sciences.
[91] E. Arbustini,et al. Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. , 2004, Gastroenterology.
[92] D. Faigel,et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. , 2002, Gastrointestinal endoscopy.
[93] B. Gridelli,et al. Contribution of Transjugular Liver Biopsy in Patients with the Clinical Presentation of Acute Liver Failure , 2006, CardioVascular and Interventional Radiology.
[94] S. Sherlock,et al. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. , 1993, The Journal of pediatrics.
[95] R. Superina,et al. Liver cell dysplasia and early liver transplantation in hereditary tyrosinemia. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[96] M. Colombo,et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.
[97] M. Banaji,et al. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. , 1982, Journal of clinical gastroenterology.
[98] D. Thorburn,et al. The Importance of Liver Biopsy in the Investigation of Possible Mitochondrial Respiratory Chain Disease , 2005, Neuropediatrics.
[99] P. Hayes,et al. Liver biopsy bleeding time: An unpredictable event , 1994, Journal of gastroenterology and hepatology.
[100] B. Konkle,et al. Defining effective therapies in transfusion medicine and hemostasis: new opportunities with the TMH Network , 2005, Transfusion.
[101] R C Nelson,et al. Percutaneous liver biopsy: a cost-benefit analysis comparing sonographic and CT guidance. , 1999, AJR. American journal of roentgenology.
[102] K. Badizadegan,et al. Focal glycogenosis of the liver in disorders of ureagenesis: Its occurrence and diagnostic significance , 1997, Hepatology.
[103] A. Tavill. Diagnosis and management of hemochromatosis , 2001, Hepatology.
[104] V. Nobili,et al. Blind and ultrasound-guided percutaneous liver biopsy in children , 2003, Pediatric Radiology.
[105] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[106] G. Remuzzi,et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. , 1983, The New England journal of medicine.
[107] C. M. Jones,et al. The diagnostic and therapeutic value of liver biopsies with particular reference to trocar biopsy. , 1947, The New England journal of medicine.
[108] C. Bodian,et al. Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[109] Z. Younossi,et al. Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C , 2004, Journal of clinical gastroenterology.
[110] R. Hanson,et al. The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.
[111] J. Mayberry,et al. A nationwide survey of liver biopsy--is there a need to increase resources, manpower and training? , 1994, Hepato-gastroenterology.
[112] Sergey V Kantsevoy,et al. Flexible transgastric peritoneoscopy and liver biopsy: a feasibility study in human beings (with videos). , 2008, Gastrointestinal endoscopy.
[113] C. Avellini,et al. The role of hepatic biopsy to detect macrovacuolar steatosis during liver procurement. , 2006, Transplantation proceedings.
[114] R. Pilkington,et al. Liver biopsy in Irish hepatitis C‐infected patients with inherited bleeding disorders , 2000, British journal of haematology.
[115] W. Frankel,et al. The value of second opinion in gastrointestinal and liver pathology. , 2001, Archives of pathology & laboratory medicine.
[116] G. Leandro,et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.
[117] J. Trotter,et al. Changes in International Normalized Ratio (INR) and Model for Endstage Liver Disease (MELD) Based on Selection of Clinical Laboratory , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[118] E. Cholongitas,et al. Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. , 2007, Journal of hepatology.
[119] A. Grant,et al. Guidelines on the use of liver biopsy in clinical practice , 1999, Gut.
[120] J. Dimmick,et al. Histopathologic Approach to Metabolic Liver Disease: Part 1 , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[121] R. Dick,et al. Liver biopsy today. The Royal Free Hospital experience. , 1985, Journal of hepatology.
[122] J. Cosín,et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[123] P. Thuluvath,et al. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.
[124] J. Janisse,et al. Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[125] J. Barbare,et al. Is bleeding time measurement useful for choosing the liver biopsy route? The results of a pragmatic, prospective multicentric study in 219 patients. , 1999, Journal of clinical gastroenterology.
[126] L. Sutherland,et al. Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. , 1987, Gastroenterology.
[127] M. Campbell,et al. Noninvasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients With Chronic Hepatitis C , 2006 .
[128] J. Pomposelli,et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. , 2002, Human pathology.
[129] I. Gilmore,et al. Plugged liver biopsy in patients with impaired coagulation , 1989, Digestive diseases and sciences.
[130] R. Wiesner,et al. Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy , 1991, Hepatology.
[131] A. Tripodi,et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests , 2005, Hepatology.
[132] A. Tripodi,et al. The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation , 2007, Hepatology.
[133] E. Brunt,et al. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[134] T. Reynolds,et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit , 2000, American Journal of Gastroenterology.
[135] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[136] A. Burroughs,et al. Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. , 2005, Journal of hepatology.
[137] Z. Goodman,et al. Liver Biopsy in Cirrhotic Patients , 2007, The American Journal of Gastroenterology.
[138] D. Häussinger,et al. Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.
[139] N. Chalasani,et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. , 2002, Gastroenterology.
[140] G. Norkrans,et al. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. , 2002, Journal of hepatology.
[141] H. Hussain,et al. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. , 2006, AJR. American journal of roentgenology.
[142] S. Caldwell. Controlling pain in liver biopsy, or “we will probably need to repeat the biopsy in a year or two to assess the response” , 2001, American Journal of Gastroenterology.
[143] T. Riley. How often does ultrasound marking change the liver biopsy site? , 1999, American Journal of Gastroenterology.
[144] J. Bruzzi,et al. Liver biopsy. , 2001, The New England journal of medicine.
[145] J. Ludwig,et al. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients , 1989, Hepatology.
[146] B. Portmann,et al. Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. , 2003, Blood.
[147] P. Clavien,et al. Medical Care of the Liver Transplant Patient , 2001 .
[148] Fen-Yu Ren,et al. Delayed hemorrhage from hepatic artery after ultrasound-guided percutaneous liver biopsy: a case report. , 2006, World journal of gastroenterology.
[149] K. Lindor,et al. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[150] Xiong Ma. [The diagnosis and treatment of autoimmune hepatitis]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[151] V. Vilgrain,et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. , 2001, Journal of hepatology.
[152] Sheng-Nan Lu,et al. Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[153] S. Verma,et al. Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver Biopsy , 2004, American Journal of Gastroenterology.
[154] J. Hoofnagle,et al. Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.
[155] P. D. James,et al. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.
[156] E. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[157] K. Boberg,et al. Is a Prolonged Bleeding Time Associated with an Increased Risk of Hemorrhage after Liver Biopsy? , 1999, Thrombosis and Haemostasis.
[158] R. Fisher,et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[159] A. Elola-Olaso,et al. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma? , 2005, Transplantation proceedings.
[160] D. Dahlin,et al. Laboratory and biopsy diagnosis of amyloidosis. , 1950, The Medical clinics of North America.
[161] E. Keeffe,et al. Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy , 2001, American Journal of Gastroenterology.
[162] M. Losowsky,et al. PERCUTANEOUS LIVER BIOPSY WITH PLUGGING OF NEEDLE TRACK: A SAFE METHOD FOR USE IN PATIENTS WITH IMPAIRED COAGULATION , 1984, The Lancet.
[163] F. Reinholt,et al. Liver biopsy interpretation for causes of late liver allograft dysfunction , 2006, Hepatology.
[164] P. Bejarano,et al. Second opinion pathology in liver biopsy interpretation , 2001, American Journal of Gastroenterology.
[165] F. Leebeek,et al. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. , 1991, Gastroenterology.
[166] M. Khuroo,et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. , 1997, The New England journal of medicine.
[167] K. Reddy,et al. Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management , 2006, Hepatology.
[168] F. Degos,et al. Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.
[169] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[170] J. Goedert,et al. Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[171] B J Ott,et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. , 1990, Gastroenterology.
[172] D. Samuel,et al. Could post‐liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? , 2005, Clinical transplantation.
[173] A. Andriulli,et al. To biopsy or not to biopsy. , 2001, Hepatology.
[174] P. Mannucci,et al. The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions. , 2008, Journal of thrombosis and haemostasis : JTH.
[175] B. Bacon,et al. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. , 1994, Gastroenterology.
[176] T. Riley,et al. The Effect of Processing on Liver Biopsy Core Size , 2008, Digestive Diseases and Sciences.
[177] B. Healy,et al. Effect of fresh‐frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities , 2006, Transfusion.
[178] T. Therneau,et al. Cost‐effectiveness of ultrasound‐guided liver biopsy , 1998, Hepatology.
[179] N. Talley,et al. Diagnostic value of liver biopsy in alcoholic liver disease. , 1988, Journal of clinical gastroenterology.
[180] M. Gambardella,et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.
[181] J. Epstein,et al. Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. , 2000, American journal of clinical pathology.
[182] K. Ewe. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation , 1981, Digestive Diseases and Sciences.
[183] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[184] P. Galle,et al. Prospective Randomized Comparison of Minilaparoscopy and Percutaneous Liver Biopsy: Diagnosis of Cirrhosis and Complications , 2007, Journal of clinical gastroenterology.
[185] Barbara J. Smith,et al. Midazolam sedation for percutaneous liver biopsy , 1993, Digestive Diseases and Sciences.
[186] A. Clouston,et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis , 1999, Hepatology.
[187] K. Batts,et al. Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.
[188] J. Trotter,et al. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease , 2007, Alimentary pharmacology & therapeutics.
[189] P. Mannucci,et al. Thrombin generation in patients with cirrhosis: The role of platelets , 2006, Hepatology.
[190] Don C Rockey,et al. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. , 2008, Gastroenterology.
[191] D. Theriaque,et al. One‐year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[192] M. Swain,et al. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? , 2005, American journal of hematology.
[193] D. Nelson,et al. Short recovery time after percutaneous liver biopsy: should we change our current practices? , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[194] A. Clouston,et al. Steatosis: Co‐factor in other liver diseases , 2005, Hepatology.
[195] J. Trotter,et al. A Survey of Current Liver Biopsy Practice Patterns , 2000, Journal of clinical gastroenterology.
[196] G Goldfarb,et al. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. , 1982, Gastroenterology.
[197] C. Brown,et al. BLEEDING IN RENAL FAILURE , 1988, The Lancet.
[198] P. Simmonds,et al. Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non‐invasive methods , 1996, British journal of haematology.
[199] A. Reuben. The legend of the lardaceous liver , 2004, Hepatology.
[200] Y. Batur,et al. Liver Biopsy: Is the Pain for Real or is it Only the Fear of it? , 2007, Digestive Diseases and Sciences.
[201] J. Madura,et al. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures. , 1994, The American surgeon.
[202] E. Cholongitas,et al. Transjugular liver biopsy in patients with diffuse liver disease: comparison of three cores with one or two cores for accurate histological interpretation , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[203] A. Gaspari,et al. Percutaneous Liver Biopsy Using an Ultrasound-Guided Subcostal Route , 2004, Digestive Diseases and Sciences.
[204] Chia-Yen Dai,et al. The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies , 2007, Gut.